342: FDA cuts, zombie biotechs, and too much weight loss?
The Readout Loud
Intro
This chapter explores the ongoing debate in the obesity field regarding the need for substantial weight loss, alongside recent FDA developments and their impact. Additionally, insights from a biotechnology analyst shed light on the industry's challenges amidst recent government cuts.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
